Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 3, 2009, Pages 227-235

  Licata, G ^a   Tuttolomondo, A ^a,b   Licata, A ^a   Parrinello, G ^a   Di Raimondo, D ^a   Di Sciacca, R ^a   CammA C ^a   CraxI A ^a   Paterna, S ^a   Pinto, A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Cattedra di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; HYPERTONIC SOLUTION; SODIUM; SPIRONOLACTONE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASCITES; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DIURESIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; INTERMETHOD COMPARISON; LEG EDEMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARACENTESIS; PLEURA EFFUSION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FUROSEMIDE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARACENTESIS; PILOT PROJECTS; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME;

EID: 67650462308     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04040.x     Document Type: Article

References (33)

1. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996 23 : 164 76.
2. Quintero E, Arroyo V, Bory F, et al. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1985 16 : 611 3.
3. Salerno F, Badalamenti S, Incerti P, et al. Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy. J Hepatol 1987 5 : 102 8.
4. Runyon BA, Morissey RL, Hoefs JC, Wyle FA. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 1985 5 : 634 7.
5. Zapater P, Francés R, González-Navajas JM, et al. Such JSerum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008 48 : 1924 31.
6. DiBona GF, Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991 260 (2 Pt 2 R298 305.
7. Di Bona GF, Herman PJ, Sawin LL. Neural control of renal function in edema forming stated. Am J Physiol 1988 254 : R1017 24.
8. Di Bona GF, Sawin LL. Renal Nerves in renal adaptation to dietary sodium restriction. Am J Physiol 1983 245 : F322 8.
9. Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987 31 : 1402 15.
10. Epstein M. The kidney in Liver Disease. Baltimore, MD : Williams and Wilkins, 1988 : 1 656.
11. Cody RJ. Diuretics in the management of congestive heart failure. Cardiologia 1998 43 : 25 34.
12. De Felippe J, Timoner J, Velasco IT, et al. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections. Lancet 1980 2 : 1002 4.
13. Maningas PA, Mattox KL, Pepe PE, et al. Hypertonic saline-dextran solutions for the prehospital management of traumatic hypotension. Am J Surg 1989 157 : 528 34.
14. Kreimeir U, Bruckner UB, Schmidt J, et al. Instantaneous restoration of regional organ blood flow after severe hemorrhage: effect of small volume resuscitation with hypertonic-hyperoncotic solutions. J Surg Res 1990 49 : 493 503.
15. Monteiro-Pacheco A, Martins Coimbra RS, Kreimer U, et al. Hypertonic volume therapy: feasibility in the prevention and treatment of multiple organ failure and sepsis. Rev Paul Med 1995 113 : 1053 60.
16. Licata G, Di Pasquale P, Parrinello G, et al. Effects of high dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure : long term effects. Am Heart Journal 2003 145 : 459 66.
17. Oliveira RP, Weingartner R, Ribas EO, Moraes RS, Friedman G. Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Med. 2002 Nov 28 (11 1574 81.
18. Ferenci P, Lockwood A, Mullen K, et al. Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002 35 : 716 21.
19. Moreau R, Lebrec D. hepatorenal syndrome-definitions and diagnosis. Aliment Pharmacol Ther 2004 20 (Suppl. 3 24 8.
20. Sanyal AJ, Genning C, Reddy KR, et al. The north american study for the treatment of refractory ascites. Gastroenterology 2003 124 : 634 41.
21. Lenaerts A, Codden TH, Henry JP, Van Cauter J, Meunier JC, Ligny G. Biological factors influencing response to diuretics in patients with cirrhosis and ascites. Gastroenterol Clin Biol 2001 25 : 268 72.
22. Beermann B, Sjogren A. Furosemide pharmacokinetics in patients with liver disease. Clin Pharmacokinet 1980 5 : 570 5.
23. Allgulander C, Sawhney VK, Gregory PB, Swezey SE, Blaschke TF. Furosemide disposition in cirrhotic patients. Gastroenterology 1981 81 : 1012 6.
24. Schroeder ET, Anderson GH, Goldman SH, Streeten DH. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kidney Int 1976 9 : 511 9.
25. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodes J. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin- angiotensin- aldosterone system in cirrhosis with ascites. Eur J Clin Invest 1981 11 : 221 9.
26. Gines P, Arroyo V, Quintero E, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987 93 : 234 41.
27. Ljubicic N, Bilic A, Kopjar B. Diuretics vs. paracentesis followed by diuretics in cirrhosis: effect on ascites opsonic activity and immunoglobulin and complement concentrations. Hepatology 1994 19 : 346 53.
28. Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007 133 : 825 34.
29. Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Hepatology 1993 18 : 519 28.
30. Paterna S, Di Pasquale P, Parrinello G, et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 2005 45 : 1997 2003. (Pubitemid 40814121)
31. Mazzoni MC, Borgstroem P, Arfors KE, et al. Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage. Am J Physiol 1988 255 : H629 37.
32. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988 8 : 1151 7.
33. Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003 23 : 259 69.